BioWorld

Sep. 13, 2010

View Archived Issues

Buyers' or Sellers' Market? Depends on Your Options

Read More

Alzheimer's NewCos Defend Gamma Secretase Targeting

Read More

Money Raised By Biotech in 2010

Read More

Week in Review

Read More

Word on the Street

Read More

Week in Washington

Read More

Next Wave of Japanese Deal-Making: Different than Last

Japanese pharmaceutical companies are taking a broad interest in U.S. and European biotechs, but both deal-making tactics and deal structures have evolved since the last headline-grabbing go-round in 2008. Read More

Money Raised Year to Date

Read More

FDA Approvals in August

Read More

Phase I Clinical Trials Update: August 2010

Read More

Phase II Clinical Trials Update: August 2010

Read More

Phase III Clinical Trials Update: August 2010

Read More

Non-U.S. Clinical Trials & Regulatory Actions: August 2010

Read More

FDA Submissions, Approvals & Other Actions: August 2010

Read More

Stock Gainers and Losers For The Week

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More